| Serial Number | 88808590 |
| Word Mark | AVIDITY BIOSCIENCES |
| Filing Date | Monday, February 24, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, September 15, 2020 |
| Registration Number | 6151953 |
| Registration Date | Tuesday, September 15, 2020 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, June 30, 2020 |
| Description of Mark | The mark consists of the wording "AVIDITY" in an all-caps font where the "A" is formed by a down-facing angle. The wording "BIOSCIENCES" appears below in a smaller all-caps font. To the left of the wording is a highly stylized design of two curved ribbons forming a diamond or partial double-helix shape. |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| NOT AVAILABLE | "BIOSCIENCES" |
| Goods and Services | Research and development in the pharmaceutical and biotechnology fields, namely, research and development for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; research and development for the use of antibody-oligonucleotide conjugates for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; medical and scientific research services for the use of antibody-oligonucleotide conjugates for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; development of pharmaceutical preparations and medicines, namely, the development of oligonucleotide-based therapeutics |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, February 27, 2020 |
| Primary Code | 042 |
| First Use Anywhere Date | Monday, December 31, 2018 |
| First Use In Commerce Date | Monday, December 31, 2018 |
| Party Name | Avidity Biosciences, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92121 |
| Party Name | Avidity Biosciences, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | La Jolla, CA 92037 |
| Party Name | Avidity Biosciences, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | La Jolla, CA 92037 |
| Event Date | Event Description |
| Thursday, February 27, 2020 | NEW APPLICATION ENTERED |
| Thursday, February 27, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, May 20, 2020 | NON-FINAL ACTION WRITTEN |
| Friday, February 28, 2020 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Tuesday, May 12, 2020 | ASSIGNED TO EXAMINER |
| Wednesday, May 20, 2020 | NON-FINAL ACTION E-MAILED |
| Wednesday, May 20, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, May 28, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, May 28, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, May 28, 2020 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, May 28, 2020 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, May 28, 2020 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, May 28, 2020 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, June 10, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, June 30, 2020 | PUBLISHED FOR OPPOSITION |
| Tuesday, June 30, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 15, 2020 | REGISTERED-PRINCIPAL REGISTER |
| Friday, February 18, 2022 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Friday, February 18, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Friday, February 18, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Friday, February 18, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, February 18, 2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Friday, September 5, 2025 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Friday, September 5, 2025 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Friday, September 5, 2025 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, September 15, 2025 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Friday, September 5, 2025 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Friday, September 5, 2025 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |